Here are relevant reports on : pharmaceutical-contract-manufacturing-market
-
Pharmaceutical Contract Manufacturing Market by Service (Drug Development, Pharmaceutical (API, FDF - Parenteral, Tablet, Capsule), Biologics (API, FDF), Packaging & Labelling, Fill-finish), Molecule (Small, Large (ADC, CGT)) - Global Forecast to 2030
The global pharmaceutical contract manufacturing market, valued at US$193.52 billion in 2024, stood at US$209.90 billion in 2025 and is projected to advance at a resilient CAGR of 8.2% from 2025 to 2030, culminating in a forecasted valuation of US$311.95 billion by the end of the period. This is mainly due to the high demand for outsourcing services for GLP-1 manufacturing, the growing ADC outsourcing for commercialized products, and the development and patent expiry of blockbuster biologics, which are paving the way for key biosimilars.
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
IVD Contract Manufacturing Services Market - Global Forecast to 2024
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Medical Device Contract Manufacturing Market by Device Type (IVD, Cardiovascular, Orthopedic, Dental), Class of Device (Class I, II, III), Service (Device Development & Manufacturing, Packaging & Assembly, Quality Management) - Global Forecast to 2030
The global medical device contract manufacturing market, valued at US$78.58 billion in 2024, stood at US$83.77 billion in 2025 and is projected to advance at a resilient CAGR of 10.9% from 2025 to 2030, culminating in a forecasted valuation of US$140.84 billion by the end of the period.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Biopharmaceutical Contract Manufacturing Market by Service (Manufacturing, Fill-Finish), Type (Drug Substance, Drug Product), Scale (Clinical), Source (Mammalian), Therapy Area (Oncology), Molecule Type (mAbs, ADC, CGT, Vaccines) - Global Forecast to 2030
The global biopharmaceutical contract manufacturing market, valued at US$20.51 billion in 2024, stood at US$22.40 billion in 2025 and is projected to advance at a resilient CAGR of 8.8% from 2025 to 2030, culminating in a forecasted valuation of US$34.15 billion by the end of the period. The growth is primarily driven by the rising demand for outsourcing services and an increasing need for biologics and biosimilars. However, challenges related to intellectual property rights are anticipated to pose barriers to market growth.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Diagnostic Contract Manufacturing Market by Device (In Vitro Diagnostic Devices and Diagnostic Imaging Devices), Service (Device Development & Manufacturing, Quality Management, and Packaging & Assembly), Application, Region - Global Forecast to 2028
The global diagnostic contract manufacturing market, valued at US$23.3 billion in 2022, stood at US$26.0 billion in 2023 and is projected to advance at a resilient CAGR of 11.5% from 2023 to 2028, culminating in a forecasted valuation of US$44.9 billion by the end of the period. The growth in this market is attributed to the rising number of diagnostic public-private partnerships, and government grants will increase the use of medical devices in emerging countries, leading to a boom in contract manufacturing.
- Published: April 2024
- Price: $ 4950
- TOC Available:
-
Medical Device Manufacturing Equipment (by Production) Market by Type (Material Processing, Sterilization & Cleaning Equipment), Application (Consumables & Disposables), End User (OEMs, Contract Manufacturing Organizations) - Global Forecast to 2030
The global medical device manufacturing equipment (by production) market, valued at US$18.0 billion in 2024, stood at US$19.24 billion in 2025 and is projected to advance at a resilient CAGR of 7.0% from 2025 to 2030, culminating in a forecasted valuation of US$27.80 billion by the end of the period. The medical device manufacturing equipment (by production) market is driven by advancements in automation, robotics, and precision machining, along with increasing demand for high-quality, regulatory-compliant devices.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
IVD Contract Manufacturing Market by Device Type (Consumables, Equipment), Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation), Service (Manufacturing, Assay Development) - Global Forecast to 2028
The global IVD contract manufacturing market, valued at US$14.2 billion in 2022, stood at US$15.4 billion in 2023 and is projected to advance at a resilient CAGR of 11.5% from 2023 to 2028, culminating in a forecasted valuation of US$26.7 billion by the end of the period. Growth in this market can primarily be attributed to the growing need for less costly and better equipment's, increased need for IVD OEMs to establish themselves in the high potential market and emerge as a budding player in other allied markets, reduced risk of development failure, and reduction in cross contamination of IVD consumables at the CMO facility, and emergence of small scaled outsourcing facilities in emerging nations.
- Published: June 2023
- Price: $ 4950
- TOC Available:
-
CRISPR Market by Product Type (Plasmids, Vectors, CAS9 Nuclease & GRNA, Delivery System), Application (Genetic Engineering, Cell Engineering) & End User (Biotechnology & Pharmaceutical Companies, Contract Research Organization) - Global Forecast to 2023
The global CRISPR market is expected to reach USD 4.16 billion by 2023 from USD 2.01 billion in 2018, growing at a CAGR of 15.7%. Increasing incidences and prevalence of genetic disorders, rising government funding on genomic research, increasing production of genetically modified crops and increasing demand for drug discovery are some of the major factors driving the growth of the global CRISPR market.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Drug Discovery Informatics Market by Function (Target Data, Sequencing Data Analysis, Docking), Solution (Software, Services), Application (Drug Development), End User (Pharmaceutical, Biotechnology, Contract Research Organizations) & Region - Global Forecast to 2025
The global drug discovery informatics market growth is primed to transition from $2.2 billion in 2020 to $3.5 billion by 2025, showcasing a strong CAGR of 9.3%. The market is primarily driven by increased R&D spending, especially in rare diseases, and the growing adoption of informatics in drug discovery.
- Published: April 2020
- Price: $ 4950
- TOC Available:
-
Protein Binding Assays Market by Technology (Equillibrium Dialysis, Ultrafiltration, Ultracentrifugation, Gel Filtration Chromatography), End User (Pharmaceutical & Biotechnology Companies, Contract Research Organization) - Global Forecast to 2023
The major players operating in the global protein binding assay market are Thermo Fisher (US), HTDialysis (US), Merck (US), GE Healthcare (US), and Absorption Systems (US). The global protein binding market is projected to reach USD 425.7 million in 2023 from USD 256.1 million in 2018, at a CAGR of 10.7%. The growing number of drug discovery activities, the minimizing drug discovery and development costs, and the increase in pharmaceutical R&D expenditure are driving the growth of this market. The key players in the global protein binding assays market are HTDialysis (US), Thermo Fisher Scientific (US), Merck (Germany), and Sovicell (Germany).
- Published: August 2018
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
